A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction.
about
Protective effects of Xinji'erkang on myocardial infarction induced cardiac injury in miceNovel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.
P2860
A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A peptide vaccine targeting an ...... uced by myocardial infarction.
@en
A peptide vaccine targeting an ...... uced by myocardial infarction.
@nl
type
label
A peptide vaccine targeting an ...... uced by myocardial infarction.
@en
A peptide vaccine targeting an ...... uced by myocardial infarction.
@nl
prefLabel
A peptide vaccine targeting an ...... uced by myocardial infarction.
@en
A peptide vaccine targeting an ...... uced by myocardial infarction.
@nl
P2093
P2860
P356
P1433
P1476
A peptide vaccine targeting an ...... uced by myocardial infarction.
@en
P2093
Hidetoshi Kumagai
Hiroshi Akazawa
Hiroshi Koriyama
Jun-Ichi Suzuki
Kouji Wakayama
Mitsuaki Isobe
Munehisa Shimamura
Ryo Watanabe
Ryuichi Morishita
Yasuhiro Maejima
P2860
P2888
P356
10.1038/SREP43920
P407
P577
2017-03-07T00:00:00Z